Alicia Y Gonzales-longoria, APRN Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 2350 Shadow Ridge Dr, Gering, NE 69341 Phone: 308-633-6202 Fax: 308-633-6203 |
Sherri Shaw, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 3350 10th St, Gering, NE 69341 Phone: 308-635-3089 |
Mrs. Brooke Arleen Vance, APRN-NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 975 Crescent Dr, Gering, NE 69341 Phone: 308-632-2540 Fax: 308-633-2650 |
Abbie Lynn Fulk, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2855 10th Street, Suite B, Gering, NE 69341 Phone: 308-633-1325 Fax: 308-633-1327 |
Mrs. Deanna L Schrotberger, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 975 Crescent Dr, Gering, NE 69341 Phone: 308-633-3280 |
Jennifer R Smith, APRN NP-C Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1605 10th St Ste B, Gering, NE 69341 Phone: 308-633-6010 Fax: 308-633-6011 |
Jodene Thomas Burkhart, ARNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3350 10th St, Gering, NE 69341 Phone: 308-635-3089 Fax: 308-635-0264 |
Katherine Grace Tuttle, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: Community Action Partnership Of Western Nebraska, 3350 10th Street, Gering, NE 69341 Phone: 308-632-2540 |
News Archive
The Lupus Research Alliance proudly announced today the 2020 Lupus Innovation Awards. The projects represent a wide breadth of scientific exploration in lupus, probing the development and progression of lupus while pointing to potential treatment approaches.
SmartDog Services, LLC, a leading provider of services for the Oracle community is pleased to introduce its new client, Examination Management Services, Inc. (EMSI).
Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a large new study reported in Circulation: Journal of the American Heart Association.
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing antibody to increase its binding affinity for the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The engineered antibody demonstrates high potency in neutralizing SARS-CoV-2 and preventing infection in animals.
› Verified 3 days ago